/Investor DB

Bold Capital Partners — 2024 Investments

4 investments dated 2024 · listed companies and verified rows first · show all

Arataarata.inin𝕏Dec 2024 · $4M

Arata develops scientifically formulated haircare products focused on biological efficacy rather than trends.

ConsumerDirect to ConsumerE-commerceHealthtechWellness & Fitness

Dhruv BhasininDhruv Madhokin

BoardSatyajit Sengupta(Chief Scientific Advisor)Dr. Vishal Kumar(Formulation Expert & Scientific Advisor)

Co-investorsDSG Consumer PartnersUnilever Ventures

Discurediscuremd.cominSeries A · Sep 2024 · $11M

DiscureMD is developing a treatment focused on disc degeneration, a leading cause of back pain that affects most adults during their lifetime.

BiotechHealthtechMedical Devices

Co-investorsSanara CapitalSupernova InvestTSVC

Figure AIfigure.aiin𝕏Feb 2024

Figure develops general-purpose humanoid robots designed for deployment in workforce and home environments.

AI & Machine LearningHardwareRoboticsSunnyvale, US

Brett Adcock(Founder)inLee Randaccio(Executive Officer)Dana Berlin(Executive Officer)Logan Berkowitz(Executive Officer)Colby Adcock(Director)Peter Welinder(Director)

Co-investors10T Fund1802 VenturesAlign VenturesAliya Capital PartnersAtaraxia CapitalAUDEO VENTURES+57 more

Holoclaraholoclara.comin𝕏Series A · Jun 2024 · $16M

Holoclara develops therapeutics derived from symbiotic intestinal organisms (helminths) that modulate inflammation, metabolism, and tissue regeneration to address chronic disease, immune-related conditions, and aging.

BiotechHealthtechLongevity

Andrea Choe(CEO / Co-Founder)inPaul W. Sternberg(Co-Founder)inFrank C. Schroeder(Co-Founder)in

Co-investorsHorizons VenturesEndurance28FREEFLOWKairos Venture Investments, LlcSV Latam Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.